Latest filing published 14 Jul 2026 for Sera Prognostics, INC..
Filing timeline
BuySaleInsider track record
Mansoor Raza Mirza: trading record in brief
This profile gathers the share dealings of Mansoor Raza Mirza across 2 companies, led by Karyopharm Therapeutics Inc. and Sera Prognostics, Inc. We count 78 filings; the first trade dates from 20 October 2014 and the latest from 10 July 2026.
Sales make up the whole of the open-market record (48 sales, €2.2M). Outside the open market, there are 4 share grants and 26 option exercises.
The record was last updated on 14 July 2026 with a share grant in Sera Prognostics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mansoor Raza Mirza
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,426 shares0Class A Common StockSEC:0001588389-26-000002:0
- 1,771 shares0Class A Common StockSEC:0001588389-26-000002:1
- 292 shares@ US$3.051.8% of flowClass A Common StockSEC:0001193125-25-309950:0
- 221 shares@ US$3.041.4% of flowClass A Common StockSEC:0001193125-25-270062:0
- 227 shares@ US$3.161.5% of flowClass A Common StockSEC:0001193125-25-231898:0
- 222 shares@ US$3.351.5% of flowClass A Common StockSEC:0001588389-25-000008:0
- 225 shares@ US$2.501.2% of flowClass A Common StockSEC:0000950170-25-103280:0
- 234 shares@ US$2.361.1% of flowClass A Common StockSEC:0000950170-25-094633:0
- 107 shares@ US$1.580.4% of flowClass A Common StockSEC:0000950170-25-083336:1
- 15,596 shares0Class A Common StockSEC:0000950170-25-083336:0
- 106 shares@ US$2.440.6% of flowClass A Common StockSEC:0000950170-25-068394:0
- 107 shares@ US$3.350.8% of flowClass A Common StockSEC:0000950170-25-052193:0
- 99 shares@ US$4.160.9% of flowClass A Common StockSEC:0000950170-25-035804:0
- 101 shares@ US$4.581.1% of flowClass A Common StockSEC:0000950170-25-021199:0
- 37,549 shares@ US$0.9178.6% of flowClass A Common StockSEC:0000950170-25-009338:0
- 100 shares@ US$7.691.8% of flowClass A Common StockSEC:0000950170-25-002823:0
- 93 shares@ US$7.121.5% of flowClass A Common StockSEC:0000950170-24-134615:0
- 95 shares@ US$7.321.6% of flowClass A Common StockSEC:0000950170-24-125652:0
- 96 shares@ US$7.151.5% of flowClass A Common StockSEC:0000950170-24-113343:0
- 96 shares@ US$7.161.5% of flowClass A Common StockSEC:0001534969-24-000182:0
- 101 shares@ US$7.421.7% of flowClass A Common StockSEC:0001534969-24-000162:0
- 7,117 shares0Class A Common StockSEC:0001534969-24-000132:0
- 5,000 shares@ US$18.00Common StockSEC:0001209191-20-064905:1
- 5,000 shares@ US$5.4319.8% of flowCommon StockSEC:0001209191-20-064905:0
- 5,000 shares@ US$16.0461Common StockSEC:0001209191-20-062319:1
25 of 78 declarations
